Mammalian genomes encode two related serine-threonine kinases, nuclear Dbf2 related (NDR)1 and NDR2, which are homologous to the Saccharomyces cerevisiae Dbf2 kinase. Recently, a yeast genetic screen implicated the Dbf2 kinase in Ty1 retrotransposition. Since several virion-incorporated kinases regulate the infectivity of human immunodeficiency virus type 1 (HIV-1), we speculated that the human NDR1 and NDR2 kinases might play a role in the HIV-1 life cycle. Here we show that the NDR1 and NDR2 kinases were incorporated into HIV-1 particles. Furthermore, NDR1 and NDR2 were cleaved by the HIV-1 protease (PR), both within virions and within producer cells. Truncation at the PR cleavage site altered NDR2 subcellular localization and inhibited NDR1 and NDR2 enzymatic activity. These studies identify two new virion-associated host cell enzymes and suggest a novel mechanism by which HIV-1 alters the intracellular environment of human cells.
Introduction
The nuclear Dbf2-related (NDR) kinases encompass a conserved subclass of the protein kinases A, G, and C (AGC) group of kinases (Tamaskovic et al., 2003a) . Mammalian genomes encode two highly related serine-threonine kinases, NDR1 and NDR2, which are approximately 87% identical at the amino acid level. Human NDR1 was initially characterized as a nuclear serine-threonine kinase homologous to the Saccharomyces cerevisiae Dbf2 kinase (Millward et al., 1995) . NDR1 and NDR2 mRNAs are ubiquitously expressed in human tissues (Devroe et al., 2004; Millward et al., 1995; Stegert et al., 2004) , and NDR1 mRNA is particularly abundant in peripheral blood leukocytes (Millward et al., 1995) . In contrast to the nuclear distribution exhibited by NDR1, NDR2 is mostly excluded from the nucleus and exhibits a punctate cytoplasmic distribution (Devroe et al., 2004; Stegert et al., 2004; Stork et al., 2004) .
Recent studies have indicated the human NDR kinases are regulated via interactions with at least two different human Mob proteins Devroe et al., 2004) . Mob proteins were first identified as kinase activating subunits in yeast , and S. cerevisiae Mob1 has been shown to bind to and regulate Dbf2 catalytic activity (Komarnitsky et al., 1998; Mah et al., 2001 ). In addition, S. cerevisiae Mob2 has been shown to interact with Cbk1 (Weiss et al., 2002) , another member of the NDR family of kinases (reviewed in Tamaskovic et al., 2003a) . Thus, Mob regulation of the NDR kinases is conserved from yeast to humans.
To date, the budding yeast Cbk1 kinase has been implicated in the maintenance of polarized growth, while the Dbf2 kinase has been linked to the regulation of the mitotic exit network (reviewed in Tamaskovic et al., 2003a) . The function(s) of mammalian NDR1 and NDR2 has not been established. However, a recent report suggests that the murine NDR2 kinase associates with the actin cytoskeleton and may play an important role in neuronal growth and differentiation (Stork et al., 2004) . Given that Mob regulation of the budding yeast NDR kinases is conserved in humans, the functions of the NDR1 and NDR2 kinases may emulate those of Dbf2 or Cbk1. Recently, a screen was performed to identify nonessential host factors that affect the life cycle of the S. cerevisiae Ty1 retrotransposon. Interestingly, this analysis determined that S. cerevisiae strains containing a DBF2 gene deletion exhibit an 8-fold defect in Ty1 retrotransposition (Griffith et al., 2003) . Since retrotransposons and retroviruses share many features in their life cycles, including reverse transcription, integration, and the formation of ribonucleoprotein particles (Coffin et al., 1997) , we hypothesized that human NDR1 and NDR2 kinases might participate in HIV-1 replication.
HIV-1 particles have been shown to incorporate at least three cellular serine-threonine kinases, ERK2/MAPK (Cartier et al., 1997; Jacque et al., 1998) , the catalytic subunit of cAMP-dependent protein kinase (C-PKA) (Cartier et al., 2003) , and an unidentified~53 kDa kinase (Cartier et al., 1997 (Cartier et al., , 1999 . ERK2/MAPK has been shown to phosphorylate the viral matrix protein and modulate HIV-1 infectivity by as much as 4-fold (Jacque et al., 1998) and to phosphorylate the viral p6 gag protein, which effects viral assembly and release (Hemonnot et al., 2004) . C-PKA was also shown to regulate HIV-1 infectivity, possibly via phosphorylation of the viral capsid (CA) protein (Cartier et al., 2003) . Given that the calculated molecular masses of NDR1 and NDR2 are~54 kDa, we considered that the unidentified~53 kDa kinase might be NDR1 or NDR2. Here we show that NDR1 and NDR2 are indeed incorporated into HIV-1 particles and are processed by the viral protease (PR).
Results

NDR1 kinase incorporation into HIV-1 particles
To test the hypothesis that the NDR1 and NDR2 kinases might be incorporated into HIV-1 particles, we began by performing Western blot analysis of sucrose gradientpurified HIV-1 IIIB using an anti-NDR1 monoclonal antibody. NDR1 was readily detected in sucrose gradientpurified HIV-1 particles (Fig. 1A) . Unfortunately, such viral preparations are frequently contaminated with cellular microvesicles possessing similar densities as retroviral particles, a fact that significantly complicates identification of virion-incorporated proteins (Bess et al., 1997; Gluschankof et al., 1997) . However, these cellular contaminants can be efficiently removed following digestion with the subtilisin protease and subsequent centrifugation through a sucrose cushion to sediment protease-resistant HIV-1 cores away from proteolyzed microvesicles (Ott et al., 1995) . Under these conditions, internal HIV-1 proteins for the most part resist protease digestion (Gurer et al., 2002; Ott et al., 1995 Ott et al., , 1996 Sova et al., 2001; Trubey et al., 2003) . Thus, digestion with subtilisin and subsequent pelleting through sucrose both greatly reduce microvesicle contamination and identify stoichiometrically recovered proteins as intravirion (Ott et al., 1995) .
To determine whether NDR1 was an HIV-associated protein or a component of cellular microvesicles, we digested sucrose gradient-purified HIV-1 IIIB and HIV-1 MN with subtilisin. As a control, we confirmed that subtilisindigested virion preparations were free of CD45 (Fig. 1B) , a known abundant component of T-cell microvesicles (Esser et al., 2001; Trubey et al., 2003) . In contrast to CD45, NDR1 was readily detected in HIV-1 IIIB and HIV-1 MN following subtilisin digestion.
Although the above result argued that NDR1 was a bona fide component of HIV-1 particles, we sought to confirm NDR1 incorporation using an independent and more easily controlled approach. Thus, we switched to a transient transfection strategy to allow direct comparison of NDR1 recovery from control versus HIV-1-producing cells. Subtilisin was used to digest sucrose-pelleted supernatants from mock or HIV-1 NL4-3 proviral DNA transfected 293T cells. As before, the protease digests were subsequently pelleted through sucrose and analyzed by Western blotting. NDR1 was not detected in the supernatant from mock-transfected cells (Fig. 1C) , which indicates NDR1 is not a component of 293T cell microvesicles. However, NDR1 was readily detected in HIV-1-containing supernatants (Fig. 1C) . Furthermore, NDR1, like internal HIV-1 proteins, was resistant to subtilisin digestion (Fig. 1C) . We note that 293T cells do not express CD45 (data not shown), and therefore confirmed that the external HIV-1 gp41 envelope protein was efficiently degraded by subtilisin (Fig. 1C) . Next, we reasoned that if NDR1 was protected from subtilisin digestion due to its presence within the HIV-1 core, it should be susceptible to digestion following physical disruption of the virions. Thus, we repeated the above experiment after first disrupting virions with Nonidet P40 (NP-40). Under these conditions, NDR1 was degraded, as were core viral proteins (Fig. 1D) . Taken together, these findings indicate that the NDR1 kinase is a true component of HIV-1 particles.
NDR2 incorporation into HIV-1 particles
Next, we sought to determine whether the NDR1 homolog NDR2 was also incorporated into HIV-1. Anti-bodies capable of detecting NDR2 were not available; therefore, we co-expressed FLAG epitope-tagged NDR2 (FLAG-NDR2) with HIV-1 in virus-producing cells. Since the results presented in the previous section demonstrated specific incorporation of endogenous NDR1 kinase into HIV-1, FLAG-NDR1 was co-expressed with HIV-1 as a comparative control. Consistent with our initial observations with endogenous NDR1 (Fig. 1C) , FLAG-NDR1 and FLAG-NDR2 were detected in sucrose-pelleted cell supernatants only upon HIV-1 co-expression (Fig. 2) . Both FLAG-NDR1 and FLAG-NDR2 were present in pelleted viral preparations following subtilisin treatment (data not shown).
Intriguingly, HIV-1 expression altered the electrophoretic mobility of a fraction of NDR1 and NDR2 both within virions and producer cell lysates (Fig. 2) , suggesting that HIV-1 might induce posttranslational modification(s) to NDR1 and NDR2. We also noted that endogenous NDR1 present within T-cell-derived HIV-1 migrated as multiple species (Figs. 1A and B) . HIV-1 particles purified from transiently transfected 293T cells contained a dominant form, although minor isoforms were also observed in these preparations (Figs. 1C and D) . Given that NDR kinase activity is regulated by phosphorylation (Devroe et al., 2004; Millward et al., 1999; Stegert et al., 2004; Tamaskovic et al., 2003b) , we reasoned HIV-1 might influence the phosphorylation status of NDR1 and NDR2. To determine whether faster migrating species represented alternately phosphorylated forms of the NDR1 and NDR2 kinases, protein lysates containing FLAGtagged NDR1 and NDR2 were treated with calf intestinal alkaline phosphatase (CIP) prior to Western blot analysis. Although each band migrated slightly faster following CIP treatment, CIP did not collapse the doublet into a single Fig. 2 . NDR2 can be incorporated into HIV-1 particles. 293T cells were cotransfected with pFLAG-NDR1 or pFLAG-NDR2 and pNL43/XmaI proviral DNA, and virus particles were pelleted through 20% sucrose. NDR1 and NDR2 were detected in pelleted material only upon HIV-1 coexpression. When cotransfected with HIV-1 proviral DNA, NDR1 and NDR2 migrated as a doublet. Sucrose gradient-purified HIV-1 IIIB and HIV-1 MN were incubated in the presence or absence of 500 Ag/ml subtilisin for 18 h at 37 8C. Whereas subtilisin removed cellular microvesicles as confirmed by anti-CD45 Western blotting, a significant fraction of NDR1 resisted proteolysis. Extracts from Jurkat T-cells serve as a positive control for both Western blots. n/a, not applicable. (C) Sucrose-pelleted virus from mock-or pNL43/XmaI-transfected 293T cells was incubated with the indicated final concentrations of subtilisin for 18 h at 37 8C. Whereas subtilisin efficiently digested the surface-exposed gp41 envelope glycoprotein, NDR1 and CA were completely resistant to proteolysis. (D) Subtilisin digestion of disrupted virions. Sucrose-pelleted virus from pNL43/XmaI-transfected 293T cells was digested overnight at 37 8C in the presence (+) or absence (À) of 500 Ag/ml subtilisin following mock treatment (À) or disruption by three rounds of freezing and thawing in the presence of 0.5% NP-40 (+). Upon physical disruption of the virions, NDR1 was digested by subtilisin, as were other internal virus proteins.
band (data not shown). Thus, HIV-1 appeared to affect an NDR1 and NDR2 posttranslational modification that was distinct from phosphorylation.
HIV-1 PR processing of the NDR1 and NDR2 kinases
We next considered the possibility that HIV-1 PR proteolytically processed NDR1 and NDR2. To test this idea, FLAG-NDR1 and FLAG-NDR2 were co-expressed in 293T cells with various proviral DNAs. Modification of NDR1 and NDR2 was induced when the kinases were coexpressed with wild-type (WT) HIV-1 NL4-3 or HIV-1 HXBX10 , but not a PR-deficient HIV-1 HXBX10 strain (Fig.  3A) . Thus, genetic evidence places the HIV-1 PR upstream of FLAG-NDR1 and FLAG-NDR2 processing.
To determine whether endogenous NDR1 was similarly processed, we examined endogenous NDR1 mobility in 293T cell lysates following mock transfection or transfection with HIV-1 NL4-3 proviral DNA. Consistent with our initial studies using exogenously expressed FLAG-NDR1 and FLAG-NDR2 (Figs. 2 and 3A), nearly half of endogenous NDR1 was likewise processed upon HIV-1 expression (Fig. 3B) . Next, we examined endogenous NDR1 processing following transfection of 293T cells with HIV-1 NL4-3 proviral DNA in the presence of Saquinavir or Nelfinavir, two small molecule inhibitors of the HIV-1 PR. Chemical inhibition of HIV-1 PR completely inhibited processing of endogenous NDR1 in HIV-1 producer cell lysates (Fig. 3B) .
Finally, we sought to determine whether PR inhibition affected incorporation of NDR1 and NDR2 into HIV-1 particles. Thus, we purified HIV-1 particles from the supernatants of 293T cells expressing FLAG-NDR1 or FLAG-NDR2 grown in the presence or absence of Saquinavir. The nonprocessed NDR1 and NDR2 were efficiently incorporated into HIV-1 particles (Fig. 3C) , which indicates that virion incorporation and proteolytic processing of NDR1 and NDR2 are physically separable events.
Functional significance of PR cleavage
Our above results demonstrated that NDR1 and NDR2 were processed in an HIV-1 PR-dependent manner, which suggested that PR directly cleaved NDR1 and NDR2. Although PR substrate specificity is not completely understood, recent experimental and computational results have highlighted several residues surrounding the scissile bond that promote or inhibit cleavage (Beck et al., 2000; Rognvaldsson and You, 2004) . Based on current understanding of PR substrate specificity, we sought to identify a PR cleavage site within NDR1 and NDR2. Since the Nterminal FLAG epitope remained following PR cleavage (Figs. 2 and 3) , we reasoned the cleavage site must be located near the NDR1 and NDR2 C-termini. Sequence inspection identified an appropriately positioned candidate PR cleavage site (Fig. 4A) , which contains highly favorable Val, Phe, and Thr residues in the P2, P1, and P4V sites, respectively (Beck et al., 2000; Rognvaldsson and You, 2004) . Intriguingly, the candidate cleavage site is located at the beginning of a hydrophobic motif conserved among Fig. 3 . The HIV-1 PR proteolytically processes NDR1 and NDR2. (A) 293T cells were cotransfected with pFLAG-NDR1 or pFLAG-NDR2 and the indicated proviral DNAs, and cell extracts were analyzed by Western blotting. The processed forms of NDR1 and NDR2 (arrowheads) were observed upon cotransfection with WT HIV-1 NL4-3 and HIV-1 HXBX10 but not following cotransfection with PR-deficient HIV-1 HXBX10 proviral DNA or a control plasmid. (B) Lysates from mock-transfected or HIV-1 NL4-3 proviral DNA-transfected 293T cells were analyzed by anti-NDR1 Western blotting. Endogenous NDR1 was processed (arrowhead) specifically following HIV-1 expression. When indicated, transfections were performed in the presence of 5 AM of the PR inhibitors Saquinavir or Nelfinavir, or an equivalent volume of the diluent dimethyl sulfoxide (DMSO). (C) 293T cells were transfected in the presence or absence of 5 AM Saquinavir with pFLAG-NDR1 or pFLAG-NDR2 and HIV-1 NL4-3 proviral DNA. Virus particles were pelleted through 20% sucrose. Cell extracts and virion lysates were analyzed by anti-FLAG Western blotting. Saquinavir inhibited processing of FLAG-NDR1 and FLAG-NDR2 in both producer cells and pelleted HIV-1 particles. Below, the polyvinylidine fluoridine membrane used for the anti-FLAG Western blot was stained with Ponceau S. As expected, processing of the p55 gag precursor (**) into p24CA (*) was inhibited in the presence of Saquinavir. almost all AGC group kinases. This motif contains a phosphoaccepting Thr residue (at the putative P4V site) known to be important for NDR1 (Tamaskovic et al., 2003a) and NDR2 kinase activity .
To confirm the location of the PR cleavage site, FLAG-NDR1 and FLAG-NDR2 expression vectors were generated with the indicated Val-Phe residues (P2 and P1 sites of the putative proteolysis site) changed to Lys-Lys (Fig. 4A) , amino acids that strongly inhibit cleavage by the HIV-1 PR (Rognvaldsson and You, 2004) . In addition, we generated C-terminally truncated (DC) expression vectors by inserting a stop codon immediately following the indicated Phe (Fig.   4A ). 293T cells were transiently transfected with the respective kinase expression vectors with or without HIV-1 NL4-3 proviral DNA. In contrast to WT NDR1 and NDR2, the mutant NDR1 and NDR2 kinases were not processed in HIV-1-expressing cells (Fig. 4B) . Furthermore, Western blot analysis demonstrated that the mobility of the truncated NDR1 and NDR2 proteins matched that of the PRprocessed forms (Fig. 4C) . Taken together, these results indicate the HIV-1 PR cleaves NDR1 and NDR2 at Phe 440 and Phe 438 , respectively, as shown in Fig. 4A . To explore potential functional consequences of PR cleavage, we analyzed the subcellular localizations of full- (Tamaskovic et al., 2003a) and NDR2 activity are highlighted by arrows. The PR-resistant (PR res ) expression vectors were constructed by mutating the coding sequence of the underlined VF residues to KK. Cterminally truncated expression (DC) vectors were constructed by inserting a stop codon (d ) following the indicated VF. (B) Western blot analysis of extracts from 293T cells transfected with WT or PR res pFLAG-NDR1 or pFLAG-NDR2 with (+) or without (À) HIV-1 NL4-3 proviral DNA. The PR res kinases, designed to disrupt the putative HIV-1 PR cleavage site, were not processed upon co-expression of HIV-1. (C) Same as in B, except that DC constructs were analyzed. The DC kinases comigrated with the PR-processed forms of NDR1 and NDR2. The DC kinases exhibited the same electrophoretic mobility upon co-expression of HIV-1 (data not shown). (D) Subcellular localization of WT and DC kinases. HeLa-CD4 cells were transiently transfected with WT or DC pFLAG-NDR1 or pFLAG-NDR2 expression vectors, and analyzed by indirect immunofluorescence microscopy. C-terminal truncation altered the subcellular distribution of NDR2 but not NDR1. (E) Analysis of WT and DC kinase activity. Full-length and truncated FLAG-NDR1 and FLAG-NDR2 were co-expressed with GFPMob2 and purified by anti-FLAG affinity purification. A mock purification (À) was performed with cells expressing only GFP-Mob2. Anti-FLAG Western blotting confirms the expression and purification of each respective kinase, while anti-GFP Western blotting demonstrates that C-terminal truncation did not inhibit GFP-Mob2 association. Kinase assays demonstrated that NDR1DC and NDR2DC retained autophosphorylation activity (auto-32 P), but were severely defective for transphosphorylation of myelin basic protein (MBP 32 P). For transphosphorylation reactions, approximately three times more NDR1 was included to compensate for the relatively low activity of NDR1 (Devroe et al., 2004) . Mock transphosphorylation reactions (À) included myelin basic protein only. length and truncated NDR1 and NDR2. Consistent with our previous findings (Devroe et al., 2004) , NDR1 accumulated in the nucleus (Fig. 4D, panel a) To determine whether C-terminal truncation affects NDR1 or NDR2 kinase activity, we purified the FLAGtagged kinases from 293T cells co-expressing GFP-Mob2. We have previously shown that Mob2 forms a heterodimer with the NDR kinases, an association that dramatically stimulates NDR1 and NDR2 auto-and transphosphorylation activity (Devroe et al., 2004) . Truncation of NDR1 and NDR2 did not inhibit their association with Mob2 or reduce their autophosphorylation activity (Fig. 4E) . However, Cterminal truncation inhibited the ability of NDR1 and NDR2 to transphosphorylate heterologous substrates such as myelin basic protein (Fig. 4E) . Kinase reactions utilizing an NDR1/2 peptide substrate yielded similar results (data not shown). Thus, C-terminal truncation at the HIV-1 PR cleavage site altered the subcellular localization of NDR2 and modified the enzymatic activity of both NDR1 and NDR2.
Discussion
Prior to these studies, HIV-1 particles were known to contain at least three cellular serine-threonine kinases: ERK2/MAPK (Cartier et al., 1997; Jacque et al., 1998) , C-PKA (Cartier et al., 2003) , and an unidentified~53 kDa kinase (Cartier et al., 1997 (Cartier et al., , 1999 . Here, we have expanded this list to include the NDR1 and NDR2 kinases and have demonstrated that the HIV-1 PR cleaves these kinases both within virus particles and within producer cells.
In the current work, we have employed the subtilisin digestion assay to recover microvesicle-free preparations of HIV-1 derived from T-cells (HIV-1 IIIB and HIV-1 MN ) and 293T cells (HIV-1 NL4-3 ) . Using a monoclonal antibody capable of detecting NDR1, we have shown that endogenous NDR1 is indeed incorporated into HIV-1 particles. Subsequently, we employed FLAG-tagged expression vectors to determine that the related NDR2 kinase is incorporated into HIV-1 particles as efficiently as NDR1. These analyses also revealed that the HIV-1 PR cleaves both kinases, a conclusion supported by four independent lines of evidence. First, NDR1 and NDR2 processing is only observed upon expression of WT, but not PR-defective, HIV-1 (Fig. 3A) . Second, two different small molecule inhibitors of the HIV-1 PR completely block processing of NDR1 and NDR2 (Figs. 3B and C, and data not shown) .
Third, a candidate cleavage site was identified near the Ctermini of NDR1 and NDR2, and mutations designed to disrupt this cleavage site completely inhibit processing (Figs. 4A and B) . Finally, NDR1 and NDR2 truncated at the identified cleavage site exhibit an electrophoretic mobility consistent with that of the processed forms of NDR1 and NDR2 (Fig. 4C) . We note that although PR-processed forms of NDR1 and NDR2 are observed both within producer cell and virion lysates, PR processing is not required for incorporation into virus particles (Fig. 3C ).
An important future direction will be to determine whether intravirion NDR1 and NDR2 kinases function to phosphorylate viral or host cell-derived proteins. Such intravirion modifications could have important functional consequences aside from those traditionally associated with phosphorylation (for example, alteration of subcellular localization or protein-protein interactions). It has been shown that serine phosphorylation within an HIV-1 PR substrate cleavage site can significantly inhibit proteolysis (Tozser et al., 1999) . The presence of serine-threonine kinases within HIV-1 particles may thus inhibit or prevent proteolytic processing of various viral or nonviral PR substrates, as previously suggested (Tozser et al., 1999) . Modulation of such PR substrates by virion-incorporated NDR1, NDR2, ERK2/MAPK, or C-PKA might therefore play important roles in HIV-1 replication.
Aside from identifying new virion-associated kinases, our studies uncovered novel mechanisms by which HIV-1 effects the intracellular environment of its host cells. Despite sharing~87% sequence identity, NDR2 predominantly localizes to the cytoplasm whereas NDR1 accumulates within the nucleus (Devroe et al., 2004; Stegert et al., 2004) . Given that NDR2 contains only a single conservative change (Arg to Lys) in the sequence defined as the NDR1 nuclear localization signal (Devroe et al., 2004; Millward et al., 1995) , the basis for this differential localization remains unknown. Our current work suggests that HIV-1 PR cleavage effects NDR2 subcellular localization, since NDR2 truncated at the PR cleavage site accumulates within the nucleus. This observation implies NDR2 residues 439-464 include a determinant responsible for its cytoplasmic distribution or nuclear exclusion. In contrast, HIV-1 PR cleavage does not affect the localization of NDR1, since NDR1 truncated at the PR cleavage site exhibits an intracellular distribution indistinguishable from that of WT NDR1.
In addition to modifying the intracellular distribution of NDR2 kinase, PR cleavage of the cell-associated NDR kinases might alter their enzymatic activity or substrate specificity. Indeed, the PR cleavage site is located at the beginning of a conserved hydrophobic motif containing a phosphoaccepting Thr residue reportedly critical for NDR1 and NDR2 activity (Millward et al., 1999; Stegert et al., 2004) . In vitro studies using purified full-length and truncated kinases indicate PR cleavage inhibits NDR transphosphorylation of a generic kinase substrate (Fig. 4E) .
These data could be interpreted as evidence that proteolysis inhibits general NDR transphosphorylation activity or that it significantly alters NDR substrate specificity. Interestingly, truncation does not appear to affect NDR1 or NDR2 autophosphorylation, which suggests that the PR-processed forms retain at least some enzymatic activity. Furthermore, NDR1 and NDR2 truncated at the HIV-1 PR cleavage site can efficiently bind their kinase activating partner Mob2 (Fig. 4E) (Devroe et al., 2004) , which is consistent with a recent report that implicates the N-termini of the NDR kinases as important for Mob binding . Additional experiments will be necessary to determine whether the PR-processed kinases are completely unable to transphosphorylate heterologous proteins, retain the ability to phosphorylate certain NDR substrates, or gain the ability to phosphorylate substrates not normally phosphorylated by full-length NDR1 and NDR2. Such findings could advance our understanding of how HIV-1 infection effects the signaling environment of the host cell.
Aside from HIV-1, we determined that endogenous NDR1 is incorporated into subtilisin-digested preparations of human T-cell lymphotrophic virus type 1 and avian myeoblastoma virus, yet we were unable to detect endogenous NDR1 in purified Moloney murine leukemia virus particles (data not shown). Given their incorporation into HIV-1 and a subset of other retroviral particles, it is tempting to speculate that NDR1 or NDR2 may play an important role in the viral life cycle, as has been suggested for HIV-associated ERK2/MAPK and C-PKA (Cartier et al., 2003; Hemonnot et al., 2004; Jacque et al., 1998) . Preliminary experiments with stable NDR1 and NDR2 bknock-downQ cell lines did not reveal a dramatic defect in viral replication (data not shown). Since such experiments yield only a partial ablation of NDR expression, more robust and specific methods of inhibition will need to be employed. The development of knockout cell lines or specific small molecule inhibitors should shed light on the potential role of NDR kinases in HIV-1 replication.
Materials and methods
Cells, protein extraction, and Western blot analysis
293T, HeLa, and HeLa-CD4 cells were grown in DMEM (Invitrogen) containing 10% fetal bovine serum and penicillin/streptomycin. Protein lysates were prepared in 20 mM HEPES pH 7.5, 150 mM NaCl, 1% sodium deoxycholate, 1% Nonidet P40 (NP-40), 0.1% sodium dodecyl sulfate (SDS), 2 mM ethylenediaminetetraacetic acid (EDTA), containing Complete Protease Inhibitors (Roche Molecular Biochemicals). Protein concentration was determined with the BioRad DC Assay kit (BioRad Laboratories). Western blotting was performed as described (Devroe and Silver, 2002) . When indicated, extracts were incubated for 15 min at 30 8C in 50 mM Tris pH 7.5, 1 mM MgCl 2 , containing 30 U of CIP (New England Biolabs) prior to Western blotting. Antibodies used in this study include monoclonal anti-NDR1 and anti-CD45 (Transduction Laboratories), monoclonal anti-FLAG M2 (Sigma), monoclonal anti-gp41 2F5 (Purtscher et al., 1994) (obtained from Hermann Katinger through the NIH AIDS Research and Reference Reagent Program), polyclonal anti-CA (Advanced Biotechnologies Inc.), and polyclonal anti-green fluorescent protein (GFP) (Seedorf et al., 1999) . HRPconjugated secondary antibodies were from Jackson ImmunoResearch Laboratories.
Viruses, virion production, and purification Sucrose gradient-purified HIV-1 IIIB and HIV-1 MN were purchased from Advanced Biotechnologies Inc. Molecular clones used in this study included HIV-1-based pNL43/ XmaI (Brown et al., 1999) , HXBH10/R+ and HXBH10/R+/ PRÀ (Bukovsky and Gottlinger, 1996) (gift of Heinrich Gottlinger). Virus stocks were produced by transient transfection of 293T cells with DNA in the presence of calcium phosphate. When indicated, transfections were performed in the presence of 5 AM Nelfinavir or Saquinvair (both from the AIDS Research and Reference Reagent Program) or the dimethyl sulfoxide (DMSO) diluent.
Digestion with subtilisin (Sigma) was performed essentially as previously described (Gurer et al., 2002; Ott et al., 1995) . Briefly, cell-free supernatants from transiently transfected cells were layered onto 6 ml 25% sucrose (w/v) prepared in 10 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA (TNE), and centrifuged for 2 h at 4 8C at 27 000 rpm in a SW28 rotor. The pelleted material was resuspended in 900 Al 10 mM Tris pH 8.0, 100 mM NaCl (TN), and incubated at 37 8C overnight following addition of 900 Al subtilisin diluted in 2Â digestion buffer (40 mM Tris pH 8.0, 2 mM CaCl 2 ). Reactions were stopped via addition of 1 mM phenylmethylsulfonyl fluoride (PMSF) (Sigma) and incubated for 20 min at room temperature. Finally, the samples were diluted in TNE (10 ml final volume), layered onto a 6 ml 25% sucrose cushion, and centrifuged as above. Pelleted material was resuspended in 2Â SDS sample buffer containing 1 mM PMSF. When indicated, pelleted virions were first resuspended in~350 Al TN, then disrupted via addition of NP-40 to 0.5%, followed by three rounds of rapid freezing and thawing. After the final thaw, the disrupted virions were diluted to 900 Al in TN and digested as above; total protein was recovered by methanol-chloroform-water precipitation as previously described Wessel and Flugge, 1984) and resuspended in 2Â SDS sample buffer containing 1 mM PMSF.
Analysis of NDR1 and NDR2 localization and activity pFLAG-NDR1, pFLAG-NDR2, and pGFP-Mob2 vectors have been previously described (Devroe et al., 2004) . To generate pFLAG-NDR1DC and pFLAG-NDR2DC, we employed the QuickChange Mutagenesis Kit (Stratagene) and oligonucleotides that introduced a stop (TGA) codon at the putative PR cleavage site. The PR res expression constructs were similarly generated using the QuickChange Mutagenesis Kit and oligonucleotides that altered the indicated Val-Phe codons to Lys-Lys. HeLa-CD4 cells were transiently transfected using FuGENE 6 transfection reagent (Roche Molecular Biochemicals) and monitored by indirect immunofluorescence microscopy using a DeltaVision platform (Applied Precision Inc.) as previously described (Devroe et al., 2004) . Kinase purification and assays were performed as previously described (Devroe et al., 2004) .
